GlassScriptPhysician profile
Charles Steven Theofilos
NPI 1861444846
$1,144,954.99
in general payments reported to CMS, 2019-2025
6 companies · $97K in 2025
The $97K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163K · 2020: $169K · 2021: $243K · 2022: $188K · 2023: $145K · 2024: $141K · 2025: $97K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $383K · Food and Beverage: $14.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $382,598.05 |
| Food and Beverage | $14.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $751,384.88 | 2019-2023 | Tlx |
| Globus Medical, INC. | $237,777.24 | 2024-2025 | Tlx |
| Stryker Corporation | $99,648.93 | 2021-2023 | Adherus Autospray Dural Sealant, Adherus Autospray Et Dural Sealant |
| Innovasis INC | $56,110.18 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.06 | 2021 | |
| Orthofix Medical, INC. | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Theofilos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.